Joseph S. Zakrzewski, Director at AN2 Therapeutics, Inc. (ANTX), sold 100,000 shares at $19.11 ($1.9M) on 2024-01-18, disclosed to the SEC on 2024-01-19.
Open-market sale of $1.9M ANTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |
| CYT | BUY | 2022-05-12 | $188K | — | Filing → |